The American Journal of Digestive Diseases

, Volume 9, Issue 12, pp 845–855 | Cite as

Immune mechanisms in chronic pancreatic disease

I. Occurrence of precipitins to pancreatic homogenales following certain forms of pancreatic damage: An experimental study
  • Donato Alarcón-Segovia
  • Teodoro Herskovic
  • Khalil G. Wakim
  • Lloyd G. Bartholomew
  • James C. Cain
Article

SUMMARY

The presence of precipitins to pancreatic antigens was investigated by gel diffusion in two experimental conditions in dogs: pancreatic-duct ligation, and ethionine-induced pancreatitis. Precipitins to the pancreas were not demonstrable after pancreatic-duct ligation, but were demonstrable in other dogs, after small doses of ethionine had been administered for a short time, and in the absence of clinical or other laboratory evidence of pancreatic damage.

Histologic study of the pancreases of dogs that were sacrificed after ethionine administration showed disruption of acini and focal inflammation. The pancreas from a dog that was kept alive for 10 weeks following ethionine administration was found to be histologically normal-even though circulating precipitins to its own pancreas had been demonstrated in this animal.

The administration of dog-pancreas antisera to normal dogs did not produce any appreciable damage to their pancreases.

Our data suggest that, in dogs, certain forms of pancreatic damage may result in the production of circulating precipitating antibodies. Their significance in the production or perpetuation of pancreatic disease is unknown, but it is possible that they have no pathogenetic significance.

Keywords

Public Health Pancreatitis Small Dose Histologic Study Immune Mechanism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Thal, A. P., Murray, M. J., andEgner, W. Isoantibody formation in chronic pancreatic disease.Lancet 1:1128, 1959.CrossRefPubMedGoogle Scholar
  2. 2.
    Thal, A. P., Egner, W., andMurray, M. J. Circulating antibodies in chronic pancreatic disease.S. Forum. 10:240, 1959.Google Scholar
  3. 3.
    Murray, M. J., andThal, A. P. The clinical significance of circulating pancreatic antibodies.Ann. Int. Med. 53:548, 1960.PubMedGoogle Scholar
  4. 4.
    Thal, A. P. The occurrence of pancreatic antibodies and the nature of the pancreatic antigen.S. Forum. 11:367, 1960.Google Scholar
  5. 5.
    Rose, N. R., Metzgar, R. S., andWitebsky, E. Studies on organ specificity. XI. Isoantigens of rabbit pancreas.J. Immunol. 85:575, 1960.PubMedGoogle Scholar
  6. 6.
    Fonkalsrud, E. W., andLongmire, W. P., Jr. The occurrence of pancreatic antibodies and the experimental production of pancreatitis with pancreatic antiserum.Surgery 50:134, 1961.PubMedGoogle Scholar
  7. 7.
    Geduldig, M. M., Reubner, B., andIber, F. L. Pancreatic lesions in inbred mice produced by Freund's adjuvant.Gastroenterology 46:175, 1964.PubMedGoogle Scholar
  8. 8.
    Beebe, S. P. Cytotoxic serum produced by the injection of nucleoproteids.J. Exper. Med. 7:733, 1905.CrossRefGoogle Scholar
  9. 9.
    Alarcón-Segovia, D., Herskovic, T., Wakim, K. G., Green, P. A., andScudamore, H. H. Presence of circulating antibodies to gluten and milk fractions in patients with nontropical sprue.Am. J. Med. 36:485, 1964.CrossRefPubMedGoogle Scholar
  10. 10.
    Thomas, J. E. The External Secretion of the Pancreas. Thomas, Springfield, Ill., 1950, pp. 18–31.Google Scholar
  11. 11.
    Herskovic, T., Alarcón-Segovia, D., Wakim, K. G., Cain, J. C., andBartholomew, L. G. Comparison between serum and urinary amylase levels in dogs. (Unpublished data.)Google Scholar
  12. 12.
    Tomasi, T. B. A precipitation reaction between human serum and a soluble tissue component.J. Immunol. 86:427, 1961.PubMedGoogle Scholar
  13. 13.
    Exgel, S., ReMine, W. H., Dockerty, M. B., Grindlay, J. H., andBartholomew, L. G. Effect of ligation of pancreatic ducts on chronic pancreatitis: Experimental study.Arch. Surg. 85:1031, 1962.Google Scholar
  14. 14.
    Kroboth, F. J., Jr., andHallenbeck, G. A. Some effects of ethionine in the dog: With particular reference to external pancreatic secretion.Gastroenterology. 27:743, 1954.PubMedGoogle Scholar
  15. 15.
    Wang, C., Paronetto, F., Sohar, E., andAdlersberg, D. Effects of ethionine administration in rabbits and dogs. I. Changes in serum proteins, lipids, lipoproteins, and glycoproteins and in blood coagulation.Arch. Path. 65:279, 1958.Google Scholar
  16. 16.
    Kahn, D. R., andCarlson, A. B. On the mechanism of experimentally induced ethionine pancreatitis.Ann. Surg. 150:42, 1959.PubMedGoogle Scholar
  17. 17.
    Witebsky, E., Rose, N. R., andNadel, H. Studies on organ specificity. X. The serologic specificity of pancreas extracts.J. Immunol. 85:568, 1960.PubMedGoogle Scholar
  18. 18.
    Pokorny, P. F., Ramsdell, J. F., andBarrett, J. T. Serum amylase changes due to antipancreas serum.Proc. Soc. Exper. Biol. & Med. 102:763, 1959.Google Scholar
  19. 19.
    Taft, L. I., Mackay, I. R., andCowling, U. C. Autoclasia: A perpetuating mechanism in hepatitis.Gastroenterology 38:563, 1960.PubMedGoogle Scholar

Copyright information

© Hoeber Medical Division • Harper & Row, Publishers, Incorporated 1964

Authors and Affiliations

  • Donato Alarcón-Segovia
    • 1
  • Teodoro Herskovic
    • 1
  • Khalil G. Wakim
    • 1
  • Lloyd G. Bartholomew
    • 1
  • James C. Cain
    • 1
  1. 1.From the Mayo Clinic and Mayo FoundationRochester

Personalised recommendations